Furthermore, it's important to note that intronic variants at position -3 in genes like NF1, TSC1, and PAH, (as indicated by HGMD database) constitute approximately 4% of causative mutations within intronic regions. The gene discussed is NF1; the disease is pulmonary arterial hypertension.